or Try an Advanced Search...

    Vascular Disease Stocks List

    Symbol Grade Name % Change
    ANGO C AngioDynamics, Inc. 2.52
    NVNO F enVVeno Medical Corporation -1.04
    AMRN F Amarin Corporation plc 1.15
    IRWD F Ironwood Pharmaceuticals, Inc. -3.13
    BCDA F BioCardia, Inc. 3.52
    REGN F Regeneron Pharmaceuticals, Inc. 1.42
    FLGT F Fulgent Genetics, Inc. -0.81
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Cardiovascular Disease Biotechnology Medicine Biopharmaceutical Bone Catheter Cholesterol Lipoprotein Therapeutic Products Vascular Access Products Veins Ablation Ablation Products Acid Aging Associated Diseases Algorithms Angiogenesis Angiography Angiology Antibodies

    Related ETFs - A few ETFs which own one or more of the above listed Vascular Disease stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 6.9
    IBB D iShares Nasdaq Biotechnology Index Fund 5.78
    IBBQ D Invesco Nasdaq Biotechnology ETF 5.76
    CANC D Tema Oncology ETF 5.25
    BIS B ProShares UltraShort Nasdaq Biotechnology 5.22
    View all Vascular Disease ETFs...
    Compare ETFs
    Compare BBH to IBB Compare IBB to CANC Compare IBB to IBBQ

        Vascular Disease Stocks Recent News

        Date Stock Title
        Nov 20 FLGT Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 REGN Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 REGN Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)
        Nov 19 REGN Regeneron: The Biotech Stock To Buy Now
        Nov 19 REGN Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
        Nov 19 AMRN After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
        Nov 19 ANGO NVRO Stock Declines Despite Positive Study Data of Nevro1 System
        Nov 19 AMRN Top 3 Health Care Stocks You'll Regret Missing In Q4
        Nov 18 REGN FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
        Nov 18 ANGO INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
        Nov 16 BCDA BioCardia Third Quarter 2024 Earnings: US$0.61 loss per share (vs US$1.79 loss in 3Q 2023)
        Nov 15 REGN FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
        Nov 15 REGN Regeneron, Sanofi say resubmitted application to expand Dupixent label accepted in U.S.
        Nov 15 REGN Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Cardiovascular Disease Biotechnology Medicine Biopharmaceutical Bone Catheter Cholesterol Lipoprotein Therapeutic Products Vascular Access Products Veins Ablation Ablation Products Acid Aging Associated Diseases Algorithms Angiogenesis Angiography Angiology Antibodies
        Vascular Disease

        Vascular disease is a term used to describe any condition that affects the circulatory system, including the arteries, veins, and capillaries. It can be caused by a variety of factors, including high blood pressure, high cholesterol, smoking, diabetes, and obesity. Vascular diseases can lead to serious health complications, such as stroke, heart attack, and peripheral artery disease.

        Browse All Tags